5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.25▲ | 1.25▲ | 1.25▲ | 1.28▼ | 1.21▲ |
MA10 | 1.26▼ | 1.26▼ | 1.26▼ | 1.20▲ | 1.13▲ |
MA20 | 1.28▼ | 1.28▼ | 1.23▲ | 1.18▲ | 1.20▲ |
MA50 | 1.21▲ | 1.21▲ | 1.26▼ | 1.14▲ | N/A |
MA100 | 1.18▲ | 1.21▲ | 1.18▲ | 1.26▲ | N/A |
MA200 | 1.16▲ | 1.24▲ | 1.22▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.009▼ | -0.006▼ | 0.002▲ | 0.010▲ | N/A |
RSI | 50.821▲ | 51.813▲ | 52.484▲ | 53.717▲ | 43.307▼ |
STOCH | 42.593 | 42.593 | 34.259 | 46.125 | 21.486 |
WILL %R | -38.889 | -38.889 | -61.111 | -58.333 | -71.622 |
CCI | -35.897 | -35.897 | -27.260 | 12.040 | 49.449 |
MA | $CTOR Price Crossed Above MA(13) | Set Alert |
Tuesday, January 07, 2025 05:16 AM
Citius Pharmaceuticals (CTXR) and its oncology-focused subsidiary, Citius Oncology (CTOR), announced progress in preparations for the commercial launch of Lymphir, an immunotherapy for the ...
|
Tuesday, January 07, 2025 05:08 AM
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius Oncology (Nasdaq: CTOR), today announced significant progress in preparations ...
|
Monday, January 06, 2025 09:21 AM
Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/01/25 | 1.30 | 1.35 | 1.19 | 1.27 | 61,400 |
22/01/25 | 1.23 | 1.34 | 1.204 | 1.32 | 92,400 |
21/01/25 | 1.23 | 1.27 | 1.17 | 1.22 | 84,502 |
17/01/25 | 1.30 | 1.3855 | 1.24 | 1.27 | 92,235 |
16/01/25 | 1.13 | 1.3899 | 1.12 | 1.32 | 157,110 |
15/01/25 | 1.09 | 1.1745 | 1.09 | 1.15 | 66,315 |
14/01/25 | 1.08 | 1.157 | 1.02 | 1.06 | 75,199 |
13/01/25 | 1.19 | 1.24 | 1.04 | 1.10 | 98,790 |
10/01/25 | 1.22 | 1.294 | 1.13 | 1.15 | 105,800 |
08/01/25 | 1.40 | 1.50 | 1.12 | 1.18 | 198,496 |
|
|
||||
|
|
||||
|
|